Nov 30, 2022
Renewed Kingston-Syracuse Pathway collaboration will help facilitate market entry into the U.S. or Canada through soft-landings initiative.
Nov 24, 2022
Most recently, Queen’s took part in the first-ever Hub350 Annual Partner Summit in Kanata, which brought together industry, financial and academic partners to celebrate and strengthen existing collaborations and build new connections
Nov 15, 2022
For Nephron.Health, the business is more than just a passion project – the team is living the experiences themselves.
Nov 10, 2022
A Queen’s research discovery has the potential to become a game-changer for breast cancer diagnosis and treatment.
Nov 08, 2022
Professor Stephen Archer and his colleagues, Dr. Danchen Wu and Dr. Michael Wells, have developed an enzyme inhibitor and early research suggests that it may be very effective in fighting cancer, Alzheimer’s disease, pulmonary hypertension.